Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research and development of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixe...
Leadership
Joel Bradley Latham
President, CEO & Executive Director
Joseph Swan
CFO, Treasurer & Secretary
Luigi M. Barbato M.D.
Chief Medical Officer
Lekhram Changoer M.Sc.
CTO & Member of Advisory Board
Mark Bleackley Ph.D.
Chief Scientific Officer, Head of Programs & Member of the Advisory Board
